Loading...
XSHE
300562
Market cap462mUSD
Jul 10, Last price  
14.68CNY
1D
2.30%
1Q
10.63%
Jan 2017
-49.25%
IPO
89.73%
Name

Guangdong Transtek Medical Electronics Co Ltd

Chart & Performance

D1W1MN
XSHE:300562 chart
P/E
39.14
P/S
3.25
EPS
0.38
Div Yield, %
1.95%
Shrs. gr., 5y
-0.37%
Rev. gr., 5y
-11.54%
Revenues
986m
+0.23%
233,075,873323,499,850380,847,702455,710,162629,005,528770,644,438866,590,293775,103,191883,668,2271,336,748,0711,821,072,4591,821,072,4591,065,096,6041,065,096,604884,256,692983,982,436986,210,596
Net income
82m
+33.63%
22,257,25828,664,41035,168,36345,339,98150,188,82380,520,71117,840,69724,015,87331,064,11970,161,7498,868,8158,868,8210-32,358,76534,367,30461,364,22781,999,096
CFO
153m
+28.62%
18,453,20018,660,90037,061,58954,250,46935,967,83478,177,014085,156,18074,957,79877,989,587084,650,66074,141,927118,850,136152,867,638
Dividend
Aug 26, 20250.13 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Guangdong Transtek Medical Electronics Co., Ltd, established in Zhongshan, China, in 2002, specializes in the development, manufacturing, and sale of various health-focused technological products within the Chinese market. The company provides a comprehensive range of offerings, including medically certified devices, internet-connected healthcare solutions, and smart wearable technology. Their product catalog features equipment for remote patient observation, blood pressure measurement tools, digital weighing scales, versatile wearable gadgets, and wireless audio devices.
IPO date
Nov 16, 2016
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122023‑002022‑122022‑002021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT